医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK1593 医美概念股

交易中 05-12 14:02:51

1,048.909

-17.416

-1.63%

最高1,078.722	最低1,045.861	成交量4,113万
今开1,065.521	昨收1,066.325	日振幅3.08%
总市值0.00	流通市值0.00	总股本0.00
成交额3.80亿	换手率--	流通股本0.00
市净率1.37254	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1048.9089,"timestamp":1778565765030,"preClose":1066.3252,"halted":0,"volume":41134653,"delay":0,"changeRate":-0.016333,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-17.41626,"latestTime":"05-12 14:02:51","open":1065.5212,"high":1078.722,"low":1045.8605,"amount":380485005,"amplitude":0.030818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778573400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1778549400000,1778558400000],[1778562000000,1778572800000]],"pbRate":1.37254,"peRate":12.357827,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK1593","defaultTab":"news","newsList":[{"id":"2634402283","title":"昊海生物科技(06826)5月11日斥资99.73万港元回购4.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634402283","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634402283?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:56","pubTimestamp":1778493365,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年5月11日，该公司斥资99.73万港元回购4.37万股股份，每股回购价22.72-22.86港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440259.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634441253","title":"复星医药子公司HLX05-N获美国FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2634441253","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634441253?lang=zh_cn&edition=full","pubTime":"2026-05-10 16:03","pubTimestamp":1778400218,"startTime":"0","endTime":"0","summary":"5月10日晚间，复星医药（600196）发布公告称，公司控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司（以下合称“复宏汉霖”）获美国FDA（即美国食品药品监督管理局）批准开展HLX05-N（即重组抗EGFR人鼠嵌合单克隆抗体注射液）用于转移性结直肠癌治疗的Ⅰ期临床试验。复宏汉霖拟于条件具备后于美国开展该药品的相关临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605103732389587.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605103732389587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0183","BK0028","BK0239","BK4585","02196","BK1593","BK4588","BK0196","BK0187","BK1191","BK0012","BK0175","BK0188","BK0060","LABU","600196","BK1515","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634144162","title":"复星医药最新公告：斯鲁利单抗注射液新增适应症获欧盟批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2634144162","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634144162?lang=zh_cn&edition=full","pubTime":"2026-05-10 15:40","pubTimestamp":1778398852,"startTime":"0","endTime":"0","summary":"复星医药公告称，公司控股子公司复宏汉霖自主研发的斯鲁利单抗注射液新增两项适应症获欧盟委员会批准，分别为联合化疗一线治疗PD-L1CPS≥5的不可切除局部晚期、复发或转移性食管鳞状细胞癌成人患者，以及联合化疗一线治疗EGFR基因突变阴性、ALK或ROS1阴性的不可手术切除局部晚期或转移性非鳞状非小细胞肺癌成人患者。该药品此前已在欧盟获批用于广泛期小细胞肺癌一线治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000002617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02196","BK0060","BK0175","BK1191","BK0183","BK0196","BK1593","BK1515","FSXEmain","600196","BK0028","BK0188","BK0012","FESXmain","BK0239","BK0096","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633439973","title":"昊海生物科技(06826)5月8日斥资120.85万港元回购5.43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633439973","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633439973?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:23","pubTimestamp":1778232189,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年5月8日，该公司斥资120.85万港元回购5.43万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633724436","title":"复星医药(02196)：盐酸文拉法辛缓释片获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2633724436","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633724436?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:11","pubTimestamp":1778231501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)公布，近日，公司控股子公司复星医药(徐州)有限公司就盐酸文拉法辛缓释片的药品注册申请获国家药品监督管理局批准，本次获批适应症为用于治疗抑郁症(包括伴有焦虑的抑郁症)及广泛性焦虑障碍。据悉，该药品为集团自主研发的化学药品。截至 2026 年 4 月，集团现阶段针对该药品的累计研发投入约为人民币 768 万元(未经审计)。该药品本次获批上市，将进一步丰富集团相关产品剂型。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","02196","600196","BK0175","BK0012","BK1191","BK0028","BK1515","BK0096","BK0188","BK0183","BK1593","BK0196","BK0060","BK0187","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179774948","title":"复星医药盐酸文拉法辛缓释片注册申请获中国国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1179774948","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179774948?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:11","pubTimestamp":1778231483,"startTime":"0","endTime":"0","summary":"上海复星医药（集团）股份有限公司宣布，其旗下药品盐酸文拉法辛缓释片的新药注册申请已正式获得中国国家药品监督管理局（NMPA）批准。\n该药物的获批标志着复星医药在精神神经疾病治疗领域的产品管线取得重要进展。盐酸文拉法辛缓释片作为一种抗抑郁药物，其上市将为中国患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK0028","BK0012","BK0175","02196","BK0183","BK0096","BK1191","BK0196","BK0060","600196","BK0188","BK0239","BK1515","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633435190","title":"四环医药(00460)建议采纳2026年股权激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2633435190","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633435190?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:37","pubTimestamp":1778229448,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药(00460)发布公告，于2026年5月8日，董事会建议采纳2026年股权激励计划。2026年股权激励计划将构成香港联合交易所有限公司证券上市规则第十七章项下之股份计划，且其条文将符合其项下之规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","BK1593","00460","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633486142","title":"医美概念股普跌 三生制药(01530)领跌2.88% 机构指美容护理板块现处于“三低”状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2633486142","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633486142?lang=zh_cn&edition=full","pubTime":"2026-05-08 13:24","pubTimestamp":1778217872,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医美概念股普跌，截至发稿，三生制药(01530)跌2.88%，卓珈控股(01827)跌2.22%，康哲药业(00867)跌2.06%，复锐医疗科技(01696)跌2.02%，四环医药(00460)跌1.61%。消息面上，华泰证券表示，美容护理板块现处于预期低/估值低/持仓低的“三低”状态，行业面/资金面/基本面等维度的边际改善均有可能带来积极变化。从财报情况来看，部分标的业绩改善迹象已现，复苏节奏和斜率略有差异。整体而言品牌商及医美上游厂商分化明显，代工厂逐步复苏，代运营商转型持续兑现。建议积极跟踪618/新品势能等催化剂，若个股有盈利预测上修潜力，戴维斯双击或可期待。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980934","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","IE00BMCWC346.EUR","01530","BK1585","SG9999015945.SGD","BK1593","BK1161","01696","IE00BYV24P56.USD","SG9999015952.SGD","SG9999015978.USD","LU2488822045.USD","HK0000165453.HKD","SG9999015986.USD","BK1600","IE00BVYPNQ40.USD","01827","BK1515","BK1100","BK1191","IE00BGHQDM52.EUR","IE00BVYPNP33.GBP","00867","00460","BK1215","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633687104","title":"【券商聚焦】中国银河：医药行业进入复苏周期 CXO板块景气度较高","url":"https://stock-news.laohu8.com/highlight/detail?id=2633687104","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633687104?lang=zh_cn&edition=full","pubTime":"2026-05-08 09:00","pubTimestamp":1778202049,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国银河证券表示，2025年医药行业上市公司营业收入增长0.4%，归母净利润增长3.9%，扣非净利润下降4.1%，2026年一季度营业收入增长1.1%，归母净利润下降3.2%，扣非净利润增长2.0%。2025全年医药行业收入端小幅微增，主要系医保控费趋严，仿制药、耗材等集采常态化开展导致行业承压。2026年一季度创新药产业链高景气度延续，收入增幅扩大、非经常性损益占比下降，行业整体经营盈利能力提升，进入复苏上行周期。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980878","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0417516571.SGD","BK1500","LU1961090484.USD","06160","BK1585","BK1207","LU0348735423.USD","LU0348767384.USD","LU0417516738.SGD","02268","09688","03933","BK1588","CXO","HK0000165453.HKD","LU0417516902.SGD","LU2778985437.USD","LU0588546209.SGD","02228","01099","LU1719994722.HKD","LU0634319403.HKD","LU0348783233.USD","LU1969619763.USD","601881","BK0276","LU1794554557.SGD","LU2328871848.SGD","BK1197","LU0561508036.HKD","LU2488822045.USD","09926","LU0307460666.USD","06881","06821","LU2476274720.SGD","02196","LU1303224171.USD","IE00BPRC5H50.USD","LU1251922891.USD","01530","BK1161","BK1141","BK1593","01789","02367","BK0188","LU0640798160.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633101233","title":"【券商聚焦】华泰证券：美容护理板块处于“三低”状态 建议积极跟踪618/新品势能等催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2633101233","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633101233?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:58","pubTimestamp":1778201918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，美容护理板块现处于预期低/估值低/持仓低的“三低”状态，行业面/资金面/基本面等维度的边际改善均有可能带来积极变化。从财报情况来看，部分标的业绩改善迹象已现，复苏节奏和斜率略有差异。整体而言品牌商及医美上游厂商分化明显，代工厂逐步复苏，代运营商转型持续兑现。建议积极跟踪618/新品势能等催化剂，若个股有盈利预测上修潜力，戴维斯双击或可期待。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1980876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","BK0028","02367","BK1215","LU0039217434.USD","BK1593","LU1064130708.USD","LU0871576103.HKD","LU1781817850.SGD","LU1808992512.USD","BK1207","BK0183","LU0531971595.HKD","BK0276","01830","LU0164865239.USD","02145","LU1979443071.USD","LU1328615791.USD","LU2242644610.SGD","601688","BK0188","LU2148510915.USD","LU0455707207.USD","LU2488822045.USD","LU1064131003.USD","BK0012","LU0502904849.HKD","LU1580142542.USD","SG9999004311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633477161","title":"云南瑞丽林下经济产业园正式开工建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2633477161","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633477161?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:48","pubTimestamp":1778158080,"startTime":"0","endTime":"0","summary":"中新网德宏5月7日电 7日，云南省德宏傣族景颇族自治州瑞丽市林下经济产业园举行开工仪式，标志着当地立足生态优势、深挖林下经济潜力、推动高原特色农业转型升级，为边疆民众增收致富、乡村全面振兴注入动能。云南省瑞丽市林下经济产业园的“橡胶＋石斛+咖啡”立体种植园。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-05-07/doc-inhxatez2700462.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-05-07/doc-inhxatez2700462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1593","02135","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144457","title":"智通港股解盘 | AI热潮从硬件扩散到应用端 马斯克概念受到追捧","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144457","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633144457?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:59","pubTimestamp":1778155199,"startTime":"0","endTime":"0","summary":"声明同时警告说，如果乌方在胜利日期间对莫斯科发动袭击，俄军将对基辅市中心实施大规模导弹打击，并呼吁平民及外国外交人员撤离基辅。希望俄乌双方保持克制，否则基辅陷入大的打击对市场会构成压力。这是自2022年11月以来连续第18个月增持黄金。当地时间周三，费城半导体指数刷新2000年3月9日以来最强五周滚动表现，该指数此期间累计涨幅超50%。中国高阶智驾仿真市场占有率达53.5%的头部企业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999015978.USD","00867","DXYZ","HK0000165453.HKD","BK1515","LU2242644610.SGD","LU2097828631.EUR","AIPO","IE00BMCWC346.EUR","SG9999004220.SGD","BK4588","IE00BYV24P56.USD","SG9999015945.SGD","SG9999015952.SGD","SG9999015986.USD","LU0455707207.USD","IE00BVYPNQ40.USD","CHAT","IE00BVYPNP33.GBP","VXUS","LU2097828714.EUR","LU2328871848.SGD","BK1583","IE00BZ08YT58.USD","LU2097828474.EUR","IE00BGHQDM52.EUR","UFO","03692","LU2097828557.USD","BK1191","IE00BZ08YS42.EUR","BK1593","LU2097828805.USD","01801","BK1521","03933","BK1161","LU1969619763.USD","BK1589","01177","LU0502904849.HKD","LU2488822045.USD","ARTY","BK4585","IE00BZ08YR35.GBP","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633149021","title":"摩根大通增持时代天使(06699)约2.94万股 每股作价约87.56港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633149021","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633149021?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:37","pubTimestamp":1778153825,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月4日，摩根大通增持时代天使(06699)2.9438万股，每股作价87.5555港元，总金额约为257.75万港元。增持后最新持股数目约为1881.65万股，最新持股比例为11.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260507/32206992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IE00BJLML261.HKD","BK1593","LU1064131342.USD","JPO","LU1162221912.USD","IE00BKVL7J92.USD","IE00BDCRKT87.USD","LU0234572021.USD","BK4550","BK4534","LU2462157665.USD","PGF","LU0496365809.HKD","LU0320765489.SGD","06699","BK4581","LU2430703251.USD","BK4207","LU2211815571.USD","LU0203347892.USD","LU2505996681.GBP","LU1261432733.SGD","LU2357627491.SGD","LU1244550221.USD","LU2106854487.HKD","LU0106261372.USD","LU0215105999.USD","LU0868494708.USD","JPMO","BK4566","IE00BBT3K403.USD","LU1032466523.USD","LU0267386448.USD","IE00B1XK9C88.USD","LU0070302665.USD","BK1100","LU2023250504.SGD","LU1894683264.USD","LU0820561909.HKD","LU1244550577.SGD","IE00BFXG1179.USD","LU1145028129.USD","EWH","LU1551013425.SGD","LU1988902786.USD","IE00BHPRN162.USD","IE00BLSP4239.USD","BK4504","LU1496350502.SGD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633018668","title":"丽丰控股(01125)：公众持股量为14.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633018668","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633018668?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:06","pubTimestamp":1778062011,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽丰控股(01125)发布公告，根据公开资料，于本公布日期(2026年5月6日)，本公司的公众持股量为14.76%，仍低于上市规则规定本公司全部已发行股本的25%须由公众人士持有之水平。本公司将持续与其控股股东、核心关连人士及财务顾问进行讨论，以寻求在合理 可行之情况下尽快恢复公众持股量。只要本公司仍未符合上市规则第13.32B条的规定，本公司将继续：定期提供有关公众持股量状况及其公众持股量恢复计划的最新进展。本公司将根据上市规则每月刊发公布，直至本公司公众持股量恢复为止，以让本公司股东及市场了解执行公众持股量恢复计划的进展;及 遵守上市规则第13.32E条之其他规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1240","BK1593","01125"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633839831","title":"复星医药（600196）披露控股子公司药品获注册批准的公告，5月6日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633839831","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633839831?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:31","pubTimestamp":1778059872,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，复星医药报收于24.77元，较前一交易日下跌0.48%，最新总市值为661.47亿元。该股当日开盘24.83元，最高24.96元，最低24.68元，成交额达5.82亿元，换手率为1.11%。近日，上海复星医药（集团）股份有限公司发布公告称，其控股子公司重庆药友制药有限责任公司获得国家药品监督管理局批准，硝普钠注射液获准上市。2025年中国境内销售额约为1.12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600027444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK1515","BK1593","BK0196","BK0187","600196","BK0028","02196","BK0188","BK0175","BK0060","BK0183","BK0012","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633183380","title":"昊海生物科技(06826)5月6日斥资187.11万港元回购8.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633183380","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633183380?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:26","pubTimestamp":1778059597,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年5月6日，该公司斥资187.11万港元回购8.52万股股份，每股回购价21.6-22.12港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631463758","title":"昊海生物科技(06826)：公司控股股东、实际控制人之一蒋伟因非本公司事项收到《取保候审决定书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2631463758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631463758?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:38","pubTimestamp":1777552710,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技 发布公告，于近日收到控股股东、实际控制人之一蒋伟先生通知，因蒋伟先生涉嫌内幕交易案侦查所需，上海市公安局出具了《取保候审决定书》，决定对蒋伟先生取保候审，期限从2026年4月29日起算。具体内容详见公司于2025年12月24日在上海证券交易所网站披露的《上海昊海生物科技股份有限公司关于公司控股股东、实际控制人之一因非本公司事项收到<行政处罚决定书>的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631685178","title":"复星医药(600196.SH)控股子公司硝普钠注射液获注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2631685178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631685178?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:27","pubTimestamp":1777537648,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(600196.SH)发布公告，近日，公司控股子公司重庆药友制药有限责任公司就硝普钠注射液的药品注册申请获国家药品监督管理局批准。本次获批适应症为(1)高血压急症，如高血压危象、高血压脑病、恶性高血压、嗜铬细胞瘤手术前后阵发性高血压等的紧急降压，也可用于外科麻醉期间进行控制性降压;(2)急性心力衰竭，包括急性肺水肿，亦用于急性心肌梗死或瓣膜(二尖瓣或主动脉瓣)关闭不全时的急性心力衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","02196","BK0028","BK0175","BK0187","BK0196","BK1515","600196","BK0239","BK0096","BK1593","BK1191","BK0183","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631506874","title":"甘蔗榨季结束，云南瑞丽边检站累计35万余吨甘蔗入境","url":"https://stock-news.laohu8.com/highlight/detail?id=2631506874","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631506874?lang=zh_cn&edition=full","pubTime":"2026-04-30 12:52","pubTimestamp":1777524720,"startTime":"0","endTime":"0","summary":"4月29日16时许，随着最后一车境外替代种植甘蔗从章凤口岸入境，预示着2025-2026甘蔗榨季正式结束，瑞丽出入境边防检查站也圆满完成了境外甘蔗返销入境保障工作。瑞丽边检民警对甘蔗车辆载运货物进行全面检查。瑞丽边检民警对入境货车司机进行信息核查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-04-30/doc-inhwhene7080839.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-04-30/doc-inhwhene7080839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02135","BK1593","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631577846","title":"港股异动 | 三生制药(01530)现涨超5% SSS68注射液三项适应症获中国IND批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2631577846","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631577846?lang=zh_cn&edition=full","pubTime":"2026-04-30 10:34","pubTimestamp":1777516454,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药现涨超5%，截至发稿，涨5.13%，报23.36港元，成交额3.02亿港元。值得一提的是，SSS68注射液是全球首个进入临床阶段的APRIL×BAFF双抗。值得注意的是，4月28日，三生制药自主研发的1类治疗用生物制品SSGJ-706注射液新药临床试验申请正式获得受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","01530","BK4588","HK0000165453.HKD","BK1583","IND","VXUS","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0198},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.1548},{"period":"ytd","weight":0.0303}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"name":"BK1593","nameEN":"BK1593"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医美概念股,BK1593,医美概念股股票,医美概念股股票老虎,医美概念股股票老虎国际,医美概念股行情,医美概念股股票行情,医美概念股股价,医美概念股股市,医美概念股股票价格,医美概念股股票交易,医美概念股股票购买,医美概念股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医美概念股(BK1593)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医美概念股(BK1593)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}